(A) Summary data showing the blockade of LTPGABA after stress. (B) Comparison of the magnitude of LTPGABA10–15 min after SNAP application. (IPSC amplitudes, control: 140 ± 5% of baseline values, n = …
(A) Summary data showing that LTPGABA is expressed in slices from naïve animals in the presence of the JNK inhibitor SP600125 (20 µM). Average magnitude of LTPGABA10–15 min after SNAP = 144 ± 13% of …
(A) Schematic of norBNI and 6β-naltrexol inhibition of κOR signaling. (B) Experimental design. (C) Representative experiment showing that bath application of norBNI (100 nM) rescues LTPGABA in a …
(A) Summary data showing that 6β-naltrexol (10 µM) does not affect basal inhibitory transmission in cells from control or stressed rats. Normalized IPSC amplitude 5–10 min after 6β-naltrexol: …
(A) Experimental design. (B) Representative experiment showing that a cell from a vehicle-treated stressed animal does not exhibit LTPGABA. (C) Representative experiment showing that a cell from an …
(A) Experimental design. (B) Representative experiment showing that a cell from a saline-treated animal exhibits LTPGABA. (C) Representative single experiment showing a cell prepared 24 hr after a …
(A) Representative experiment showing that norBNI (100 nM) does not potentiate excitatory synapses on Ih+ VTA neurons in a slice prepared from a control animal. (B) Representative experiment showing …
(A) Experimental design. (B) Lever pressing during the final extinction session (white bar) and reinstatement session (colored bar). Saline (black): last extinction session: 6.4 ± 1.7 lever presses; …
(A) During stress, dynorphin binding to the κOR triggers a shift to a constitutively active state. By blocking dynorphin binding, both norBNI and 6β-naltrexol prevent the loss of LTPGABA during this …